dicyclomine and semaglutide – julymd SpaDerma | Semaglutide | Tirzepatide

Direct answer: FDA worries because compounded GLP-1 drugs do not go through the same FDA approval process for safety, quality, effectiveness, and labeling as approved drugs

This was a GLP-1-based therapy, mechanistically, that did not influence cardiovascular risk

Be open about what youre experiencingeven if it feels awkward to talk about

(1) Given that osteoarthritis (OA) is the leading indication for arthroplasty and obesity is the most significant modifiable risk factor for OA development, it is unsurprising that a substantial proportion of arthroplasty patients are affected by obesity

Pregnant women should avoid both medications, as they may cause harm to the fetus